Ειδήσεις: GENE THERAPY | PXAI

22/04 18:00 statnews.com

STAT+: Gene therapy trial for deafness adds evidence to drug’s efficacy

CLINICAL TRIALS GENE THERAPY POLITICS STAT+BIOTECH DISABILITY

07/04 14:00 startribune.com

Deadly diseases in Minnesota newborns to be targeted in new whole-genome study

newborn genetics whole‑genome sequencing gene therapy privacy concerns Minnesota health genetic testing

07/04 12:03 dev.to

The Letter That Was Wrong

CPS1 deficiency in vivo base editing personalized gene therapy urea cycle disorder neonatal treatment metabolic disease

06/04 14:03 nbcnews.com

A one-time treatment tweaked their genes — and lowered their cholesterol

gene editing cholesterol cardiovascular drug adherence one‑time treatment medical breakthrough

04/04 23:29 cbsnews.com

Scientist with rare ALS genetic mutation looks to experimental treatment

ALS genetic mutation experimental therapy spinal infusion Jeff Vierstra neurodegenerative disease

03/04 11:50 sciencedaily.com

Deafness reversed: One injection restores hearing in just weeks

gene therapy hearing restoration deafness inner ear injection clinical trial auditory gene

02/04 00:45 ktla.com

UCLA-led gene therapy approved by FDA for rare, life-threatening immune disorder

gene therapy FDA approval UCLA leukocyte adhesion deficiency Kresladi rare immune disorder

01/04 12:00 nbcnews.com

They're in a race to save their children with a rare disease. A newly approved drug has given them hope.

Hunter syndrome rare disease new drug family hope pediatric

31/03 18:06 yahoo.com

Why Alnylam Pharmaceuticals Inc. (ALNY) is One of the Best High Growth Healthcare Stocks to Buy Now

Alnylam RNAi high‑growth biotech healthcare stocks gene therapy

31/03 18:06 yahoo.com

Why Alnylam Pharmaceuticals Inc. (ALNY) is One of the Best High Growth Healthcare Stocks to Buy Now

Alnylam RNAi high‑growth biotech healthcare stocks gene therapy

Loading...